English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/87786
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Combination of biological screening in a cellular model of viral latency with virtual screening identifies novel compounds that reactivate HIV-1

AuthorsGallastegui, Edurne; Luque, Neus ; Terme, Jean-Michel ; Gatell, Josep M.; Jordan, Albert
Issue Date2012
PublisherAmerican Society for Microbiology
CitationJournal of Virology 86(7): 3795-3808 (2012)
AbstractAlthough highly active antiretroviral therapy (HAART) has converted HIV into a chronic disease, a reservoir of HIV latently infected resting T cells prevents the eradication of the virus from patients. To achieve eradication, HAART must be combined with drugs that reactivate the dormant viruses. We examined this problem in an established model of HIV postintegration latency by screening a library of small molecules. Initially, we identified eight molecules that reactivated latent HIV. Using them as templates, additional hits were identified by means of similarity-based virtual screening. One of those hits, 8-methoxy-6-methylquinolin-4-ol (MMQO), proved to be useful to reactivate HIV-1 in different cellular models, especially in combination with other known reactivating agents, without causing T-cell activation and with lower toxicity than that of the initial hits. Interestingly, we have established that MMQO produces Jun N-terminal protein kinase (JNK) activation and enhances the T-cell receptor (TCR)/CD3 stimulation of HIV-1 reactivation from latency but inhibits CD3-induced interleukin-2 (IL-2) and tumor necrosis factor alpha (TNF-α) gene transcription. Moreover, MMQO prevents TCR-induced cell cycle progression and proliferation in primary T cells. The present study documents that the combination of biological screening in a cellular model of viral latency with virtual screening is useful for the identification of novel agents able to reactivate HIV-1. Moreover, we set the bases for a hypothetical therapy to reactivate latent HIV by combining MMQO with physiological or pharmacological TCR/CD3 stimulation.
Descriptionet al.
Publisher version (URL)http://dx.doi.org/10.1128/JVI.05972-11
URIhttp://hdl.handle.net/10261/87786
DOI10.1128/JVI.05972-11
Identifiersdoi: 10.1128/JVI.05972-11
issn: 0022-538X
e-issn: 1098-5514
Appears in Collections:(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
Combination of biological.pdf1,56 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.